Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RAIS

Financiado

Cerrado

Scalable point of care and label free microarray platform for rapid detection o...

Scalable point of care and label free microarray platform for rapid detection of Sepsis The diagnosis and management of acute Sepsis is a critical area where fast and accurate results can translate into life changing health outcomes for individuals. The overall aim of RAIS is to develop a new point-of-care label-free... ver más

31/03/2018

FUNDACIO INSTITUT...

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

FUNDACIO INSTITUT DE CIENCIES FOTONIQUES Otra investigación y desarrollo experimental en ciencias naturales y técnicas asociacion

TRL 4-5 | 50K€

Fecha límite participación Sin fecha límite de participación.

Ver 11 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-03-31

ICT-26-2014: Photonics KET Scope:Specific Challenge: Europe's photonics industry is facing fierce global market competition and...

I+D

Cerrada hace 10 años

0% 88% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

11 Participantes

FUNDACIO INSTITUT DE CIENCIE...

812.95K€ | Lider

FUNDACIO INSTITUT CATALA DE...

246.41K€ | Participante

EPFL

400.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CE-MICROARRAY Cavity Enhanced Microarray as an Ultra sensitive Tool to aid... 2M€ Cerrado

MuMiPOC Multiparametric Microfluidic System for the Point Of Care de... 176K€ Cerrado

HEMOSPEC Advanced spectroscopic hemogram for personalized care agains... 5M€ Cerrado

PoC-Cycle Innovative Molecular Diagnostics point of care device for MR... 71K€ Cerrado

ECLectic ElectroChemiLuminescence doctoral network for early sepsis d... Cerrado

PARCIVAL Partner Network for a Clinically Validated Multi Analyte Lab... 4M€ Cerrado

Duración del proyecto: 39 meses Fecha Inicio: 2014-12-08
Fecha Fin: 2018-03-31

Líder del proyecto

FUNDACIO INSTITUT DE CIENCIES FOTONIQUES Otra investigación y desarrollo experimental en ciencias naturales y técnicas asociacion

TRL 4-5 | 50K€

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The diagnosis and management of acute Sepsis is a critical area where fast and accurate results can translate into life changing health outcomes for individuals. The overall aim of RAIS is to develop a new point-of-care label-free microarray platform and validate it for quantifying levels of specific Sepsis’ biomarkers. The approach uses a novel interferometric technique ultimately capable of providing very large arrays of tests. Specific objectives and activities include: (i) an optical microarray reader based on a disruptive proprietary design combining interferometric lens-free microscopy and proximity CCD or CMOS image sensing; (ii) a microarray plate, in a proper microfluidic cartridge, consisting of a transparent slide with a novel nano-structured surface geometry to increase the detection sensitivity and covered by specific receptors to capture bio-markers; (iii) their integration in a portable and battery powered label free microarray platform potentially capable of measuring more than 1 million bio-targets simultaneously. The developed technology will be capable to detect micro-ribonucleic acids (microRNAs), interleukins and other specific proteins associated to Sepsis using a few microliters of blood or serum samples, in a concentration of a few pg/ml, within 30 minutes (sample to result) and at a cost per patient of less than 50€. In this way, patients will be put on the right treatment more rapidly, potentially reducing the Sepsis mortality rate of more than 70%, with estimated cost savings of more than €10 billion per year as a consequence of shorter hospital stays, reduced use of unnecessary drugs and lower associated insurance bills. The technical approach, targeted device, application and the addressed market sector are perfectly in line with the call H2020-ICT-2014-1 - Photonics KET - Biophotonics for screening of diseases: Mobile, low-cost point-of-care screening devices for reliable, fast and non- or minimally-invasive detection of diseases.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores